Search U.S. Product Recalls Database

Showing 14041–14060 of 14362 results

Sort:

Tizanidine 4mg Tablets (Stat Rx USA) – Label Mix-Up (2012)

Labeling: Label Mix-Up; Some bottles of Tizanidine 4mg Tablets, had the incorrect manufacturer (Actavis) printed on the label.

Class IIILow

FDAJul 23, 2012Nationwide• Stat Rx USA

Synthroid 50 mcg Tablets (Abbott) – Defective Container (2012)

Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.

Class IIModerate

FDAJul 19, 2012Nationwide• Abbott Laboratories

Stay Informed

Search Product Recalls

Tizanidine 4mg Tablets (Stat Rx USA) – Label Mix-Up (2012)

Synthroid 50 mcg Tablets (Abbott) – Defective Container (2012)

Synthroid 75 mcg Tablets (Abbott) – Defective Container (2012)

Synthroid 112 mcg Tablets (Abbott) – Defective Container (2012)

Ketoconazole Cream 2% (Fougera) – Specification Failure (2012)

Walgreens Tension Headache Caplets (LNK) – Undeclared Ingredient (2012)

X-ROCK 3 Day Pill (Coral Rock Man) – Unapproved Ingredients (2012)

Z-ROCK Male Supplement (Coral Rock Man) – Unapproved Ingredients (2012)

Daytrana Patch 30mg (Noven) – delivery system defect (2012)

Infants' Mapap Acetaminophen (Axcentria) – incorrect expiration (2012)

Daytrana Patch 20mg (Noven) – delivery system defect (2012)

Daytrana Patch 15mg (Noven) – delivery system defect (2012)

Fentanyl Transdermal System (Actavis) – subpotent medication (2012)

Levothroid 112 mcg (Lloyd Inc.) – Manufacturing Specification Issue (2012)

Levothroid 50 mcg (Lloyd Inc.) – Manufacturing Specification Issue (2012)

Thyro-Tab 0.050 mg (Lloyd Inc.) – Manufacturing Specification Issue (2012)

Thyro-Tab 0.112 mg (Lloyd Inc.) – Manufacturing Specification Issue (2012)

Thyro-Tab 0.300mg (Lloyd) – manufacturing specification (2012)

Levothroid 137 mcg (Lloyd Inc.) – Manufacturing Specification Issue (2012)

Thyro-Tab 0.125 mg (Lloyd Inc.) – Manufacturing Specification Issue (2012)